This website uses cookies

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.

Some cookies on this site are essential, and the site won't work as expected without them. These cookies are set when you submit a form, login or interact with the site by doing something that goes beyond clicking on simple links.

We also use some non-essential cookies to anonymously track visitors or enhance your experience of the site. If you're not happy with this, we won't set these cookies but some nice features of the site may be unavailable.

Press ReleasesIn the MediaAwardsScientific PublicationsRelated LinksSubscription Press MailingMedia Contact

Press Releases

ITM today announced the establishment of a Chinese subsidiary in Shanghai, that will be part of the ITM Group as a wholly foreign-owned entity (WFOE)…

Read more

Financing led by Petrichor Healthcare Capital Management strengthens company’s global position as a leader in precision oncology and the field of…

Read more

First pivotal study to compare PRRT in patients with Grade 1 and 2 GEP-NETs with approved standard of care

Read more

ITM has signed two strategic agreements with Telix for the global supply of ITM’s highly pure therapeutic radioisotope no-carrier-added Lutetium-177

Read more

ITM will present an e-poster on the COMPETE phase III trial with lead candidate n.c.a. 177Lu-Edotreotide, a Targeted Radionuclide Therapy for GEP-NETs

Read more

GeGant® for the U.S. market will be produced and distributed by ITM’s long-term partner RadioMedix

Read more